Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (FcαRI) CD89

被引:12
|
作者
Pleass, RJ [1 ]
Dehal, PK [1 ]
Lewis, MJ [1 ]
Woof, JM [1 ]
机构
[1] Univ Dundee, Sch Med, Dept Mol & Cellular Pathol, Dundee, Scotland
关键词
D O I
10.1046/j.1365-2567.2003.01677.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human immunoglobulin A (IgA) mediates protective effector mechanisms through interaction with specific cellular Fc receptors (FcalphaRI). Two IgA Fc interdomain loops (Leu257-Leu258 in the CH2 domain and Pro440-Phe443 in the CH3 domain) have previously been identified as critical for binding to FcalphaRI. On the receptor, the interaction site for IgA has been localized to the EC1 domain. The essential FcalphaRI residues involved are Tyr35, Tyr81 and Arg82, with contributions also from Arg52 and to a lesser extent from His85 and Tyr86. The basic nature of the side chains of some of the receptor residues implicated in ligand binding suggested that charge matching might play some role in the interaction. To address this possibility, we have generated five IgA1 mutants with point substitutions in acidic residues lying close to the putative interaction site and assessed their abilities to bind FcalphaRI on human neutrophils. Mutants E254A, E254L and E437A displayed affinities for FcalphaRI comparable to that of wild-type IgA1, while mutants D255A and D255V had only slightly reduced affinities for the receptor. Therefore, electrostatic interactions appear unlikely to play a significant role in the IgA-FcalphaRI interaction. Moreover, the lack of effect of mutations in residues adjacent to those previously implicated in binding, reaffirms the importance of the interdomain loops in FcalphaRI binding.
引用
收藏
页码:331 / 335
页数:5
相关论文
共 50 条
  • [1] The Fc receptor for IgA (FcαRI, CD89)
    Otten, MA
    van Egmond, M
    IMMUNOLOGY LETTERS, 2004, 92 (1-2) : 23 - 31
  • [2] Identification and characterization of macaque CD89 (immunoglobulin A Fc receptor)
    Rogers, KA
    Scinicariello, F
    Attanasio, R
    IMMUNOLOGY, 2004, 113 (02) : 178 - 186
  • [3] CD89 (FcαRI)
    Van Spriel, AB
    van de Winkel, JGJ
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (02): : 179 - 181
  • [4] Crosslinking of the human Fc receptor for IgA (FcαRI/CD89) triggers FcR γ-chain-dependent shedding of soluble CD89
    van Zandbergen, G
    Westerhuis, R
    Mohamad, NK
    van de Winkel, JGJ
    Daha, MR
    van Kooten, C
    JOURNAL OF IMMUNOLOGY, 1999, 163 (11): : 5806 - 5812
  • [5] CD89: the human myeloid IgA Fc receptor
    Morton, HC
    Brandtzaeg, P
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2001, 49 (03) : 217 - 229
  • [6] Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR γ chain on myeloid cells in blood and tissue
    Hamre, R
    Farstad, IN
    Brandtzaeg, P
    Morton, HC
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2003, 57 (06) : 506 - 516
  • [7] Functionality of the IgA Fc receptor (FcαR, CD89) is down-regulated by extensive engagement of FcεRI
    Matsui, Takashi
    Nunomura, Satoshi
    Shimokawa, Toshibumi
    Yoshimaru, Tetsuro
    Ra, Chisei
    CLINICAL IMMUNOLOGY, 2008, 129 (01) : 155 - 162
  • [8] Immunoglobulin-binding sites of human FcαRI (CD89) and bovine Fcγ2R are located in their membrane-distal extracellular domains
    Morton, HC
    van Zandbergen, G
    van Kooten, C
    Howard, CJ
    van de Winkel, JGJ
    Brandtzaeg, P
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11): : 1715 - 1722
  • [9] The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity
    Bakema, J. E.
    van Egmond, M.
    MUCOSAL IMMUNOLOGY, 2011, 4 (06) : 612 - 624
  • [10] The Fc receptor for IgA (FcαRI, CD89) as cytotoxic trigger molecule in lymphoma therapy.
    Stockmeyer, B
    Repp, R
    Wachter, Y
    Dechant, M
    Valerius, T
    Gramatzki, M
    BLOOD, 2003, 102 (11) : 303B - 303B